About the Pituitary Research Program
The Pituitary Research Program at the Icahn School of Medicine at Mount Sinai is engaged in a number of research studies and clinical trials that provide access to novel medical therapies and individualized long-term follow up for patients with pituitary tumors and pituitary disorders. Led by principal investigator Eliza B. Geer, MD, current studies explore the mechanisms of pituitary tumor development and the safety and efficacy of treating patients with Cushing’s disease and acromegaly with new medications, among other topics.
The Pituitary Research Program also develops databases of patients in order to generate data for research and enable thorough, long-term follow-up care. These databases help Dr. Geer and her team to quickly identify patients who could potentially benefit from new experimental therapies. One of the databases includes more than 400 patients with Cushing’s disease and tracks their long-term outcomes after receiving treatment. Data from this ongoing study was published in a 2013 article in the Journal of Clinical Endocrinology & Metabolism. Another large database follows prolactinoma patients, tracking their symptoms at presentation, remission rates with surgical or medical treatment, and quality of life over time. Read more
We are investigating new therapies for patients with Cushing’s disease and acromegaly. Learn more
The Pituitary Research Program’s interdisciplinary team includes experts in endocrinology and neurosurgery. Read more